Showing results (111-120 of 405) with videos related to

Sort By:
Pageof 41
Multiple Sclerosis and Related Disorders|June 6, 2022
Hiding in plain sight: The magnitude of unused disease modifying therapies in multiple sclerosis and strategies for reducing the economic burden of careDarin T Okuda, Katy W Burgess, Karin Cook, et al.
Neurology and Therapy|December 19, 2022
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple SclerosisCaroline Ruetsch-Chelli, Darin T Okuda, Fanny Rocher, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2020
Depression in multiple sclerosis across the adult lifespanCarol K Chan, Fan Tian, Daniela Pimentel Maldonado, et al.
Multiple Sclerosis and Related Disorders|July 27, 2016
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trialsTobias Derfuss, Daniel Ontaneda, Jacqueline Nicholas, et al.
Current Neurology and Neuroscience Reports|June 28, 2024
Artificial Intelligence and Multiple SclerosisMoein Amin, Eloy Martínez-Heras, Daniel Ontaneda, et al.
Multiple Sclerosis and Related Disorders|August 3, 2025
Cognitive profiles associated with faster thalamic atrophy in multiple sclerosisMoein Amin, Keeley Scullin, Kunio Nakamura, et al.
Multiple Sclerosis and Related Disorders|June 21, 2022
Racial disparities in hypertension management among multiple sclerosis patientsDevon S Conway, Farren Bs Briggs, Ellen M Mowry, et al.
Multiple Sclerosis and Related Disorders|August 25, 2019
Vitamin D and MRI measures in progressive multiple sclerosisJustin R Abbatemarco, Robert J Fox, Hong Li, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2019
Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in uteroAndrew L Smith, Jeffrey A Cohen, Daniel Ontaneda, et al.
Medicine and Science in Sports and Exercise|August 3, 2023
Quantifying the Association between Objectively Measured Physical Activity and Multiple Sclerosis in the UK BiobankQier Meng, Erjia Cui, Andrew Leroux, et al.
Pageof 41